FDA and Vioxx
FDA and Vioxx
This paper examines the part the FDA played in the Vioxx issue.
4,500 words (
approx. 18 pages) |
20 sources |
2006
Paper Summary:
This paper examines the FDA, an agency that is a regulatory and public health agency that oversees most food products (other than meat and poultry), human and animal drugs, therapeutic agents of biological origin, medical devices, radiation-emitting products used by doctors and the consumer, cosmetics and animal feed. Its role in the Vioxx problem is discussed, along with possible solutions.
From the Paper:
"Drugs are introduced to the marketplace after what may have been years of development, a long series of trials and the presentation of test results to the Food and Drug Administration (FDA) for approval. The agency is a regulatory and public health agency that oversees most food products (other than meat and poultry), human and animal drugs, therapeutic agents of biological origin, medical devices, radiation-emitting products used by doctors and the consumer, cosmetics and animal feed. The agency began with a single chemist in the U.S. Department of Agriculture in 1862 and now has a staff of approximately 9,100 employees and a budget of $1.294 billion, including chemists, pharmacologists, physicians, microbiologists, veterinarians, pharmacists, lawyers and so on."
FDA and Vioxx (2012, January 15). Retrieved February 11, 2012, from http://www.academon.com/Research-Paper-FDA-and-Vioxx/90400
"FDA and Vioxx" 15 January 2012. Web. 11 Feb. 2012. <http://www.academon.com/Research-Paper-FDA-and-Vioxx/90400>